PHRRF logo

PHRRF PharmaTher Holdings Ltd.

Other OTC · Biotechnology · Healthcare

$0.03
-0.00 (-11.11%)

PharmaTher Holdings Ltd. operates as a clinical-stage biotechnology firm, primarily focused on psychedelic compounds. It is dedicated to investigating, advancing, and bringing to market innovative applications, formulations, and administration techniques for psychedelics to treat a range of conditions including mental health disorders, neurological ailments, and chronic pain. A key asset in its de…

Market Cap: $2.91Mwww.pharmather.com

Price

No data yet.

Social Signal Score

63
5d
—
30d
58
2 mentions
—
60d
65
4 mentions
—
90d
65
4 mentions
—
news: 4

Revenue

$0.00
$0.00
Aug 2020Aug 2026

Analyst Estimates

FY2025
$-0.10
$-0.10–$-0.10
1 analysts
FY2026
$-0.08
$-0.08–$-0.08
1 analysts
FY2027
$-0.04
$-0.04–$-0.04
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Fabio Chianelli
Sector
Healthcare
Industry
Biotechnology
Employees
5
Beta
2.36
Country
CA
Piotroski score
1 / 9 (Weak)
Altman Z-score
-15.98
www.pharmather.com